EVMN · Evommune Inc. Common Stock
View on chartInsiders & Stakes
| LSP 7 Cooperative UA | ▲ Buy | Grant | 5,288,313 Shares held | 2/17/2026 | View profile |
| Verduyn-van Weegen Felice Isabel | ▲ Buy | Grant | 5,288,313 Shares held | 2/17/2026 | View profile |
| RA CAPITAL MANAGEMENT, L.P. Director | ▲ Buy | Grant | 2,710,293 Shares held | 2/17/2026 | View profile |
| Pena Luis C. President & CEO | ▼ Sell | Open Market | 630,458 Shares held | 6/22/2026 | View profile |
| Pivotal bioVenture Partners Fund I, L.P. Director | ▼ Sell | Other | 294,502 Shares held | 11/7/2025 | View profile |
| Bauer Eugene Chief Medical Officer | ▼ Sell | Tax Withholding | 270,818 Shares held | 12/9/2025 | View profile |
| Drew Janice Suzann EVP, Operations | ▼ Sell | Open Market | 67,794 Shares held | 6/22/2026 | View profile |
| Gregory S. Moss Chief Business & Legal Officer | ▼ Sell | Open Market | 60,835 Shares held | 5/28/2026 | View profile |
| Carver Kyle Chief Financial Officer | ▲ Buy | Open Market | 60,335 Shares held | 7/8/2026 | View profile |
| Patel Jeegar Pravinkumar Chief Scientific Officer | ▼ Sell | Open Market | 46,403 Shares held | 6/22/2026 | View profile |
| Cohen David E | ▼ Sell | Open Market | 17,609 Shares held | 6/2/2026 | View profile |
| Arthur S. Kirsch Director | ▲ Buy | Open Market | 10,000 Shares held | 7/7/2026 | View profile |
| Hopfner Robert Lorne | ▲ Buy | Open Market | 4,026 Shares held | 12/19/2025 | View profile |
Transaction History
| Carver Kyle | ▲ Buy | Open Market | 1,000 | $13K | 7/8/2026 |
| Arthur S. Kirsch | ▲ Buy | Open Market | 10,000 | $133K | 7/7/2026 |
| Pena Luis C. | ▼ Sell | Open Market | 7,438 | $169K | 6/22/2026 |
| Drew Janice Suzann | ▲ Buy | Option Exercise | 3,839 | $15K | 6/22/2026 |
| Drew Janice Suzann | ▲ Buy | Option Exercise | 16,161 | $48K | 6/22/2026 |
| Drew Janice Suzann | ▼ Sell | Open Market | 20,000 | $453K | 6/22/2026 |
| Patel Jeegar Pravinkumar | ▲ Buy | Option Exercise | 1,488 | $6K | 6/22/2026 |
| Patel Jeegar Pravinkumar | ▼ Sell | Open Market | 1,488 | $33K | 6/22/2026 |
| Cohen David E | ▼ Sell | Open Market | 5,456 | $110K | 6/2/2026 |
| Cohen David E | ▼ Sell | Open Market | 600 | $13K | 6/2/2026 |
| Patel Jeegar Pravinkumar | ▲ Buy | Option Exercise | 13,512 | $52K | 6/1/2026 |
| Patel Jeegar Pravinkumar | ▼ Sell | Open Market | 16,687 | $379K | 6/1/2026 |
| Pena Luis C. | ▼ Sell | Open Market | 16,787 | $382K | 6/1/2026 |
| Gregory S. Moss | ▲ Buy | Option Exercise | 14,223 | $24K | 5/28/2026 |
| Gregory S. Moss | ▼ Sell | Open Market | 14,223 | $325K | 5/28/2026 |
| Carver Kyle | ▲ Buy | Option Exercise | 15,000 | $45K | 5/28/2026 |
| Carver Kyle | ▼ Sell | Open Market | 18,175 | $415K | 5/28/2026 |
| LSP 7 Cooperative UA | ▲ Buy | Grant | 358,680 | $10.0M | 2/17/2026 |
| Verduyn-van Weegen Felice Isabel | ▲ Buy | Grant | 358,680 | $10.0M | 2/17/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Grant | 35,868 | $1000K | 2/17/2026 |
| Hopfner Robert Lorne | ▲ Buy | Open Market | 1,000 | $17K | 12/19/2025 |
| Pena Luis C. | ▼ Sell | Tax Withholding | 28,138 | $502K | 12/9/2025 |
| Patel Jeegar Pravinkumar | ▼ Sell | Tax Withholding | 7,513 | $134K | 12/9/2025 |
| Gregory S. Moss | ▼ Sell | Tax Withholding | 13,624 | $243K | 12/9/2025 |
| Drew Janice Suzann | ▼ Sell | Tax Withholding | 5,074 | $91K | 12/9/2025 |
| Carver Kyle | ▼ Sell | Tax Withholding | 13,290 | $237K | 12/9/2025 |
| Bauer Eugene | ▼ Sell | Tax Withholding | 1,478 | $26K | 12/9/2025 |
| Verduyn-van Weegen Felice Isabel | ▼ Sell | Other | 3,367,133 | — | 11/7/2025 |
| Verduyn-van Weegen Felice Isabel | ▲ Buy | Open Market | 1,562,500 | $25.0M | 11/7/2025 |
| Pena Luis C. | ▼ Sell | Other | 24,225 | — | 11/7/2025 |
| Patel Jeegar Pravinkumar | ▼ Sell | Other | 3,175 | — | 11/7/2025 |
| Gregory S. Moss | ▼ Sell | Other | 3,175 | — | 11/7/2025 |
| Hopfner Robert Lorne | ▼ Sell | Other | 3,026 | — | 11/7/2025 |
| Hopfner Robert Lorne | ▼ Sell | Other | 1,441,032 | — | 11/7/2025 |
| Hopfner Robert Lorne | ▼ Sell | Other | 1,632,441 | — | 11/7/2025 |
| Hopfner Robert Lorne | ▼ Sell | Other | 294,502 | — | 11/7/2025 |
| Drew Janice Suzann | ▼ Sell | Other | 1,587 | — | 11/7/2025 |
| Cohen David E | ▼ Sell | Other | 6,056 | — | 11/7/2025 |
| Pivotal bioVenture Partners Fund I, L.P. | ▼ Sell | Other | 1,441,032 | — | 11/7/2025 |
| Pivotal bioVenture Partners Fund I, L.P. | ▼ Sell | Other | 1,632,441 | — | 11/7/2025 |
| Pivotal bioVenture Partners Fund I, L.P. | ▼ Sell | Other | 294,502 | — | 11/7/2025 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Other | 1,517,329 | — | 11/7/2025 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Other | 691,441 | — | 11/7/2025 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 1,157,096 | $18.5M | 11/7/2025 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 92,904 | $1.5M | 11/7/2025 |
| LSP 7 Cooperative UA | ▼ Sell | Other | 3,367,133 | — | 11/7/2025 |
| LSP 7 Cooperative UA | ▲ Buy | Open Market | 1,562,500 | $25.0M | 11/7/2025 |
| Carver Kyle | ▼ Sell | Other | 3,175 | — | 11/7/2025 |
| Bauer Eugene | ▼ Sell | Other | 25,812 | — | 11/7/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Evommune to Present Phase 2a Data for EVO301 at EADV Congress
Evommune will present late‑breaker Phase 2a results for its atopic dermatitis drug EVO301 at the European Academy of Dermatology & Venereology Congress. The presentation follows a setback with its earlier candidate EVO756, shifting focus to the more promising EVO301. The company’s pipeline reset underscores the importance of these data for its future prospects.
Evommune to Present Phase 2a Data for EVO301 at EADV Congress. Evommune will present late‑breaker Phase 2a results for its atopic dermatitis drug EVO301 at the European Academy of Dermatology & Venereology Congress. The presentation follows a setback with its earlier candidate EVO756, shifting focus to the more promising EVO301. The company’s pipeline reset underscores the importance of these data for its future prospects.